Cargando…

The effect of combined oral contraception on testosterone levels in healthy women: a systematic review and meta-analysis

BACKGROUND: Combined oral contraceptives (COCs) reduce levels of androgen, especially testosterone (T), by inhibiting ovarian and adrenal androgen synthesis and by increasing levels of sex hormone-binding globulin (SHBG). Although this suppressive effect has been investigated by numerous studies ove...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zimmerman, Y., Eijkemans, M.J.C., Coelingh Bennink, H.J.T., Blankenstein, M.A., Fauser, B.C.J.M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2014
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3845679/ https://www.ncbi.nlm.nih.gov/pubmed/24082040 http://dx.doi.org/10.1093/humupd/dmt038

Ejemplares similares

Unique effects on hepatic function, lipid metabolism, bone and growth endocrine parameters of estetrol in combined oral contraceptives
por: Mawet, Marie, et al.
Publicado: (2015)

Testosterone suppression combined with high dose estrogen as potential treatment of SARS-CoV-2. A mini review
por: Coelingh Bennink, Herjan J.T., et al.
Publicado: (2022)

Treatment of Serious COVID-19 with Testosterone Suppression and High-dose Estrogen Therapy
por: Coelingh Bennink, Herjan J.T., et al.
Publicado: (2021)

Mild ovarian stimulation for IVF is the smartest way forward
por: Nargund, G., et al.
Publicado: (2020)

Approaches to improve the diagnosis and management of infertility
por: Devroey, P., et al.
Publicado: (2009)

Cell mediated immunity in healthy women taking oral contraceptives.
por: Dwyer, J. M., et al.
Publicado: (1975)

Reply to Bexultan Kazybay and Yingqiu Xie’s Letter to the Editor re: Herjan J.T. Coelingh Bennink, Jean-Michel Foidart, Frans M.J. Debruyne. Treatment of Serious COVID-19 with Testosterone Suppression and High-dose Estrogen Therapy. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.06.024
por: Coelingh Bennink, Herjan J.T., et al.
Publicado: (2021)

Functional genetic polymorphisms and female reproductive disorders: Part I: polycystic ovary syndrome and ovarian response
por: Simoni, M., et al.
Publicado: (2008)

Functional genetic polymorphisms and female reproductive disorders: Part II—endometriosis
por: Tempfer, C.B., et al.
Publicado: (2009)

Lack of pharmacokinetic interaction between the HIV‐1 maturation inhibitor GSK3640254 and combination oral contraceptives in healthy women
por: Pene Dumitrescu, Teodora, et al.
Publicado: (2021)

Effect of Prucalopride on the Pharmacokinetics of Oral Contraceptives in Healthy Women
por: Van de Velde, Vera, et al.
Publicado: (2013)

Use of Combined Oral Contraceptives in Perimenopausal Women
por: Cho, Moon Kyoung
Publicado: (2018)

Oral Contraceptives Impair Complex Emotion Recognition in Healthy Women
por: Pahnke, Rike, et al.
Publicado: (2019)

Inhibition of ovulation by administration of estetrol in combination with drospirenone or levonorgestrel: Results of a phase II dose-finding pilot study
por: Duijkers, Ingrid J.M., et al.
Publicado: (2015)

Target expression is a relevant factor in synthetic lethal screens
por: Schultz, Iman J., et al.
Publicado: (2022)

Comparative efficacy of statins, metformin, spironolactone and combined oral contraceptives in reducing testosterone levels in women with polycystic ovary syndrome: a network meta-analysis of randomized clinical trials
por: Almalki, Hussain H., et al.
Publicado: (2020)

Oral contraceptive use and risk of melanoma in premenopausal women
por: Feskanich, D, et al.
Publicado: (1999)

Breast cancer and combined oral contraceptives.
por: Shelton, J. D.
Publicado: (1990)

Oral contraceptives and the serotonin 4 receptor: a molecular brain imaging study in healthy women
por: Larsen, S. V., et al.
Publicado: (2020)

Using self-supervised feature learning to improve the use of pulse oximeter signals to predict paediatric hospitalization
por: Mwaniki, Paul, et al.
Publicado: (2023)

Tumor suppression, dose-limiting toxicity and wellbeing with the fetal estrogen estetrol in patients with advanced breast cancer
por: Schmidt, Marcus, et al.
Publicado: (2020)

Effect of exenatide on the pharmacokinetics of a combination oral contraceptive in healthy women: an open-label, randomised, crossover trial
por: Kothare, Prajakti A, et al.
Publicado: (2012)

Cancers in Australia in 2010 attributable to and prevented by the use of combined oral contraceptives
por: Jordan, Susan J, et al.
Publicado: (2015)

Cardiometabolic health in offspring of women with PCOS compared to healthy controls: a systematic review and individual participant data meta-analysis
por: Gunning, Marlise N, et al.
Publicado: (2020)

Oral contraceptives and breast cancer.
por: Chilvers, C. E., et al.
Publicado: (1990)

Associations of different hormonal contraceptive methods with hair concentrations of cortisol, cortisone, and testosterone in young women
por: Carrillo Vázquez, Mariana, et al.
Publicado: (2022)

A double-blind, non-inferiority RCT comparing corifollitropin alfa and recombinant FSH during the first seven days of ovarian stimulation using a GnRH antagonist protocol
por: Devroey, P., et al.
Publicado: (2009)

Oral contraceptives and survival in breast cancer.
por: Millard, F. C., et al.
Publicado: (1987)

Lack of effect of oral cabotegravir on the pharmacokinetics of a levonorgestrel/ethinyl oestradiol‐containing oral contraceptive in healthy adult women
por: Trezza, Christine, et al.
Publicado: (2017)

Regulatory T Cell Proportion and Phenotype Are Altered in Women Using Oral Contraception
por: Moldenhauer, Lachlan M, et al.
Publicado: (2022)

Effect of the Monthly Injectable Combined Contraceptives versus Oral Contraceptive Pills on Mood
por: Khafagy, Ghada M., et al.
Publicado: (2021)

Fasted plasma asprosin concentrations are associated with menstrual cycle phase, oral contraceptive use and training status in healthy women
por: Leonard, A. N., et al.
Publicado: (2020)

Effects of oral contraceptives on metabolic parameters in adult premenopausal women: a meta-analysis
por: Silva-Bermudez, Lina S, et al.
Publicado: (2020)

The efficacy and safety of luteal phase support with progesterone following ovarian stimulation and intrauterine insemination: A systematic review and meta-analysis
por: Casarramona, G., et al.
Publicado: (2022)

Multinational, multicentre, randomised, open-label study evaluating the impact of a 91-day extended regimen combined oral contraceptive, compared with two 28-day traditional combined oral contraceptives, on haemostatic parameters in healthy women
por: Nappi, Rossella E., et al.
Publicado: (2014)

Improving combined contraceptive pill/oral contraceptives prescribing in general practice
por: Russell, Sophie, et al.
Publicado: (2017)

Extended regimen combined oral contraception: A review of evolving concepts and acceptance by women and clinicians
por: Nappi, Rossella E., et al.
Publicado: (2016)

Estetrol‐Drospirenone combination oral contraceptive: a clinical study of contraceptive efficacy, bleeding pattern and safety in Europe and Russia
por: Gemzell‐Danielsson, K, et al.
Publicado: (2021)

Meta-analysis of oral contraceptives and rheumatoid arthritis risk in women
por: Qi, Shuang, et al.
Publicado: (2014)

Pharmacokinetics of a Prototype Formulation of Sublingual Testosterone and a Buspirone Tablet, Versus an Advanced Combination Tablet of Testosterone and Buspirone in Healthy Premenopausal Women
por: van Rooij, Kim, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_euk95dm4a1420u7kb8mmab79d6